Mary E. Davis

651 total citations
26 papers, 467 citations indexed

About

Mary E. Davis is a scholar working on Molecular Biology, Health, Toxicology and Mutagenesis and Cancer Research. According to data from OpenAlex, Mary E. Davis has authored 26 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Health, Toxicology and Mutagenesis and 5 papers in Cancer Research. Recurrent topics in Mary E. Davis's work include Cancer, Hypoxia, and Metabolism (3 papers), Neuroscience and Neuropharmacology Research (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Mary E. Davis is often cited by papers focused on Cancer, Hypoxia, and Metabolism (3 papers), Neuroscience and Neuropharmacology Research (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Mary E. Davis collaborates with scholars based in United States. Mary E. Davis's co-authors include Tai Akera, Thomas Brody, Harihara M. Mehendale, William O. Berndt, John M. Yuhas, Jingting Li, John B. Barnett, Yon Rojanasakul, Ming Pei and Bing‐Hua Jiang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Mary E. Davis

26 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary E. Davis United States 14 204 95 71 64 56 26 467
Renate Thiel Germany 13 233 1.1× 63 0.7× 91 1.3× 91 1.4× 52 0.9× 31 581
Winsome F. Walker United States 13 541 2.7× 38 0.4× 62 0.9× 59 0.9× 25 0.4× 16 710
Andrew D. Burdick United States 12 710 3.5× 255 2.7× 141 2.0× 29 0.5× 94 1.7× 16 1.1k
Michał Toborek Poland 9 166 0.8× 46 0.5× 92 1.3× 13 0.2× 37 0.7× 16 503
Sergei Romanov United States 8 329 1.6× 104 1.1× 142 2.0× 45 0.7× 95 1.7× 9 676
D. S. Loose-Mitchell United States 11 201 1.0× 82 0.9× 50 0.7× 30 0.5× 83 1.5× 18 645
Kathryn E. Plant United Kingdom 14 292 1.4× 76 0.8× 82 1.2× 15 0.2× 49 0.9× 30 541
Desiree I. Palen United States 8 200 1.0× 134 1.4× 167 2.4× 20 0.3× 29 0.5× 9 548

Countries citing papers authored by Mary E. Davis

Since Specialization
Citations

This map shows the geographic impact of Mary E. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary E. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary E. Davis more than expected).

Fields of papers citing papers by Mary E. Davis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary E. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary E. Davis. The network helps show where Mary E. Davis may publish in the future.

Co-authorship network of co-authors of Mary E. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Mary E. Davis. A scholar is included among the top collaborators of Mary E. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary E. Davis. Mary E. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pizzute, Tyler, Jingting Li, Ying Zhang, Mary E. Davis, & Ming Pei. (2016). Fibroblast Growth Factor Ligand Dependent Proliferation and Chondrogenic Differentiation of Synovium-Derived Stem Cells and Concomitant Adaptation of Wnt/Mitogen-Activated Protein Kinase Signals. Tissue Engineering Part A. 22(15-16). 1036–1046. 22 indexed citations
2.
Zhang, Ying, Jingting Li, Mary E. Davis, & Ming Pei. (2015). Delineation of in vitro chondrogenesis of human synovial stem cells following preconditioning using decellularized matrix. Acta Biomaterialia. 20. 39–50. 26 indexed citations
3.
Teng, Bunyen, Jonathan D. Smith, Michael E. Rosenfeld, et al.. (2014). A1 adenosine receptor deficiency or inhibition reduces atherosclerotic lesions in apolipoprotein E deficient mice. Cardiovascular Research. 102(1). 157–165. 16 indexed citations
4.
Stueckle, Todd A., Yongju Lu, Mary E. Davis, et al.. (2012). Chronic occupational exposure to arsenic induces carcinogenic gene signaling networks and neoplastic transformation in human lung epithelial cells. Toxicology and Applied Pharmacology. 261(2). 204–216. 70 indexed citations
5.
Luanpitpong, Sudjit, Neelam Azad, Liying Wang, et al.. (2012). Multifunctional Role of Bcl-2 in Malignant Transformation and Tumorigenesis of Cr(VI)-Transformed Lung Cells. PLoS ONE. 7(5). e37045–e37045. 30 indexed citations
6.
Spalding, Aaron C., Benjamin D. Zeitlin, Kari Wilder-Romans, et al.. (2008). Enzastaurin, an inhibitor of PKCβ, Enhances Antiangiogenic Effects and Cytotoxicity of Radiation against Endothelial Cells. Translational Oncology. 1(4). 195–IN1. 13 indexed citations
7.
Spalding, Aaron C., Richard Watson, Mary E. Davis, et al.. (2007). Inhibition of Protein Kinase Cβ by Enzastaurin Enhances Radiation Cytotoxicity in Pancreatic Cancer. Clinical Cancer Research. 13(22). 6827–6833. 19 indexed citations
8.
Yang, Huimin & Mary E. Davis. (1997). Dichloroacetic acid pretreatment of male and female rats increases chloroform-induced hepatotoxicity. Toxicology. 124(1). 63–72. 8 indexed citations
9.
Yang, Huimin, et al.. (1996). Dichloroacetic Acid Treatment Increases Hepatic CYP2E1 in Male and Female Rats. Toxicology and Applied Pharmacology. 141(2). 382–388. 5 indexed citations
10.
Davis, Mary E.. (1992). Dichloroacetic acid and trichloroacetic acid increase chloroform toxicity. Journal of Toxicology and Environmental Health. 37(1). 139–148. 13 indexed citations
11.
Davis, Mary E.. (1990). Subacute toxicity of trichloroacetic acid in male and female rats. Toxicology. 63(1). 63–72. 12 indexed citations
12.
Davis, Mary E., et al.. (1989). Mechanism of allyl formate-induced hepatotoxicity in rainbow trout. Toxicology and Applied Pharmacology. 98(2). 313–324. 9 indexed citations
13.
Davis, Mary E., et al.. (1989). Alterations in the renal function of male and female rats exposed to maleic acid, dichloromaleic acid, and both compounds. Toxicology. 56(3). 229–238. 2 indexed citations
14.
Davis, Mary E.. (1988). Effects of AT-125 on the nephrotoxicity of hexachloro-1,3-butadiene in rats. Toxicology and Applied Pharmacology. 95(1). 44–52. 20 indexed citations
15.
Davis, Mary E., William O. Berndt, & Harihara M. Mehendale. (1986). Effects of cysteine and diethylmaleate pretreatments on renal function and response to a nephrotoxicant. Archives of Toxicology. 59(1). 7–11. 7 indexed citations
16.
Goodman, Robert L., Robert E. Moore, Mary E. Davis, David Stokes, & John M. Yuhas. (1984). Perfluorocarbon emulsions in cancer therapy: Preliminary observations on presently available formulations. International Journal of Radiation Oncology*Biology*Physics. 10(8). 1421–1424. 22 indexed citations
17.
Yuhas, John M., et al.. (1982). Circumvention of the tumor membrane barrier to WR-2721 absorption by reduction of drug hydrophilicity. International Journal of Radiation Oncology*Biology*Physics. 8(3-4). 519–522. 31 indexed citations
18.
Davis, Mary E., William O. Berndt, & Harihara M. Mehendale. (1980). Disposition and nephrotoxicity of hexachloro-1,3-butadiene. Toxicology. 16(3). 179–191. 30 indexed citations
19.
Davis, Mary E. & Harihara M. Mehendale. (1979). ABSENCE OF METABOLISM OF MORPHINE DURING ACCUMULATION BY ISOLATED PERFUSED RABBIT LUNG. Drug Metabolism and Disposition. 7(6). 425–428. 11 indexed citations
20.
Davis, Mary E., Tai Akera, & Thomas Brody. (1979). Reduction of opiate binding to brainstem slices associated with the development of tolerance to morphine in rats.. Journal of Pharmacology and Experimental Therapeutics. 211(1). 112–119. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026